BioNTech share price fell over 20% in the past month-Is share price reflecting vaccine failure, and its likely consequences, which may include shareholder and vaccine user class action.
by Ganesh Sahathevan BioNTech's share price over the past month does not seem to reflect the enthusiasm governments the world over for vaccination, and boosters. Is the market sensing, given data from Israel, Singapore, that the Pfizer-BioNTech vaccine is failing, and that apart from falling revenue, there will be user and investor class action? END SEE ALSO https://sg.news.yahoo.com/ singapore-plans-5000-daily- new-covid-cases-ong-ye-kung- 103202576.html Singapore to ramp up plans to handle 5,000 daily new COVID cases: Ong Ye Kung Wong Casandra·Senior Reporter Fri, 24 September 2021, 8:32 pm·4-min read In this article: Ong Ye Kung Singaporean politician Health Minister Ong Ye Kung speaks at a COVID-19 multi-ministry taskforce on 24 September, 2021. (PHOTO: MCI) SINGAPORE — Singapore will start ramping up plans to be ready to handle 5,000 daily new COVID-19 cases, said Health Minister Ong Ye Kung on Friday (24 September), amid an ongoing coronav...